NEW YORK (GenomeWeb News) – Decode Genetics disclosed in a filing with the US Securities and Exchange Commission yesterday that it will not make its scheduled Oct. 15 interest payment on its outstanding 3.5 percent convertible notes due 2011.

The cash-strapped firm said that it has to pay the interest within 30 days after the Oct. 15 date, or it will be in default under terms of the indentures securing the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.